| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99215 |
Prolong outpt/office vis |
695 |
650 |
$76K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
905 |
838 |
$71K |
| 90688 |
|
364 |
352 |
$4K |
| 92553 |
|
103 |
99 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
126 |
120 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
224 |
212 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25 |
24 |
$1K |
| 86580 |
|
166 |
156 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
18 |
18 |
$270.26 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
319 |
296 |
$267.65 |
| 99173 |
|
110 |
106 |
$243.30 |
| 94760 |
|
52 |
50 |
$118.86 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
85 |
81 |
$3.36 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
28 |
14 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$0.00 |